CLINICAL TRIALS PROFILE FOR TROPHAMINE 10%

All Clinical Trials for TROPHAMINE 10%

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00005775 ↗	Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants	Completed	National Center for Research Resources (NCRR)	Phase 3	1999-07-01	This large multicenter double-masked clinical trial tested whether supplementation of standard neonatal parenteral nutrition with glutamine would reduce the risk of death or late-onset sepsis in extremely-low-birth-weight (ELBW, less than or equal to 1000 gm) infants. Neonates with birth weights of 401-1000gm were randomized to standard TrophAmine or TrophAmine supplemented with glutamine before 72 hours and continued until the infants are tolerating full enteral feedings.
NCT00005775 ↗	Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants	Completed	NICHD Neonatal Research Network	Phase 3	1999-07-01	This large multicenter double-masked clinical trial tested whether supplementation of standard neonatal parenteral nutrition with glutamine would reduce the risk of death or late-onset sepsis in extremely-low-birth-weight (ELBW, less than or equal to 1000 gm) infants. Neonates with birth weights of 401-1000gm were randomized to standard TrophAmine or TrophAmine supplemented with glutamine before 72 hours and continued until the infants are tolerating full enteral feedings.
NCT00005889 ↗	Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion	Unknown status	Baylor College of Medicine	N/A	1999-10-01	RATIONALE: Very low birth weight infants have problems maintaining normal blood sugar levels. Gluconeogenesis is the production of sugar from amino acids and fats. The best combination of amino acids, fat, and sugar to help very low birth weigh infants maintain normal blood sugar levels is not yet known. PURPOSE: Clinical trial to study how very low birth weight infants break down amino acids, fat, and sugar given by intravenous infusion, and the effect of different combinations of nutrients on the infants' ability to maintain normal blood sugar levels.
NCT00005889 ↗	Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion	Unknown status	National Center for Research Resources (NCRR)	N/A	1999-10-01	RATIONALE: Very low birth weight infants have problems maintaining normal blood sugar levels. Gluconeogenesis is the production of sugar from amino acids and fats. The best combination of amino acids, fat, and sugar to help very low birth weigh infants maintain normal blood sugar levels is not yet known. PURPOSE: Clinical trial to study how very low birth weight infants break down amino acids, fat, and sugar given by intravenous infusion, and the effect of different combinations of nutrients on the infants' ability to maintain normal blood sugar levels.

Clinical Trial Conditions for TROPHAMINE 10%

Condition Name

Condition Name for TROPHAMINE 10%
Intervention	Trials
Infant, Low Birth Weight	2
Infant, Newborn	1
Infant, Premature	1
Infant, Small for Gestational Age	1

Condition MeSH

Condition MeSH for TROPHAMINE 10%
Intervention	Trials
Birth Weight	2
Hyperglycemia	1
Body Weight	1
Premature Birth	1

Clinical Trial Locations for TROPHAMINE 10%

Trials by Country

Trials by Country for TROPHAMINE 10%
Location	Trials
United States	13

Trials by US State

Trials by US State for TROPHAMINE 10%
Location	Trials
Texas	2
Florida	1
Connecticut	1
California	1
Alabama	1

Clinical Trial Progress for TROPHAMINE 10%

Clinical Trial Phase

Clinical Trial Phase for TROPHAMINE 10%
Clinical Trial Phase	Trials
Phase 3	1
N/A	1

Clinical Trial Status

Clinical Trial Status for TROPHAMINE 10%
Clinical Trial Phase	Trials
Unknown status	1
Completed	1

Clinical Trial Sponsors for TROPHAMINE 10%

Sponsor Name

Sponsor Name for TROPHAMINE 10%
Sponsor	Trials
National Center for Research Resources (NCRR)	2
NICHD Neonatal Research Network	1
Baylor College of Medicine	1

Sponsor Type

Sponsor Type for TROPHAMINE 10%
Sponsor	Trials
NIH	2
Other	2